financetom
Business
financetom
/
Business
/
Railroad operator Norfolk Southern's quarterly profit rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Railroad operator Norfolk Southern's quarterly profit rises
Jul 29, 2025 4:36 AM

(Corrects to add dropped word "adjusted" in paragraph 2)

(Reuters) -Norfolk Southern ( NSC ) reported a rise in its second-quarter profit on Tuesday, aided by higher revenue from improved volumes.The East Coast railroad operator's quarterly adjusted profit rose to $3.29 per share, from $3.06 per share a year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Self-proclaimed bitcoin inventor faces contempt of court case over $1.2 bln UK lawsuit
Self-proclaimed bitcoin inventor faces contempt of court case over $1.2 bln UK lawsuit
Nov 1, 2024
LONDON, Nov 1 (Reuters) - An Australian computer scientist who claimed he invented bitcoin was on Friday accused of contempt of court after he filed a 911 million-pound ($1.18 billion) lawsuit against Twitter founder Jack Dorsey's payments firm Block in Britain. Craig Wright claimed to have been the author of the foundational text of bitcoin published under the pseudonym Satoshi...
Char Technologies Raises $3.27 Million in Private Placement
Char Technologies Raises $3.27 Million in Private Placement
Nov 1, 2024
08:44 AM EDT, 11/01/2024 (MT Newswires) -- Char Technologies ( CTRNF ) on Friday said it has closed its non-brokered private placement, raising $3.27 million to advance the Thorold Project in Ontario to biocarbon production The company issued 16.4 million units at $0.20 each. Each unit consists of one share and half a warrant. Each two-year warrant can buy an...
Sutro Biopharma Opens Enrollment for Luveltamab Tazevibulin Trial
Sutro Biopharma Opens Enrollment for Luveltamab Tazevibulin Trial
Nov 1, 2024
08:46 AM EDT, 11/01/2024 (MT Newswires) -- Sutro Biopharma ( STRO ) said Friday it has opened enrollment for its registration-directed study of the drug luveltamab tazevibulin in children with a certain type of acute myeloid leukemia. The trial is global and the majority of the sites are planned to be open by the end of the year, the company...
Abbott Laboratories Found Not Responsible for Boy's Intestinal Disease by Missouri Jury in Baby Formula Trial
Abbott Laboratories Found Not Responsible for Boy's Intestinal Disease by Missouri Jury in Baby Formula Trial
Nov 1, 2024
09:01 AM EDT, 11/01/2024 (MT Newswires) -- Abbott (ABT) and UK-based Reckitt's Mead Johnson were cleared by a jury Thursday of responsibility for a young boy's intestinal disease in a lawsuit over baby formulas for premature babies, according to multiple media reports. Lawyers for the plaintiff during the five-week trial in a Missouri state court urged jurors to award more...
Copyright 2023-2026 - www.financetom.com All Rights Reserved